The California Health Care Foundation and the Center for Care Innovations have partnered with the Weitzman Institute to develop a new program to help health care providers throughout California treat opioid-addicted patients. Providers will participate in real-time case discussions with primary care practitioners actively treating substance abuse and addiction .For details, please read the Weitzman ECHO Addiction Treatment Program Press Release.
Buprenorphine is one of the most effective, evidence-based interventions for treating opioid abuse and reducing overdose, but few primary care providers have experience with the therapy or understand how to incorporate it into their practice. The Weitzman ECHO creates virtual classrooms for primary care providers and members of their practice teams to improve their skills and gain confidence in treating patients’ substance use disorders. Providers who have participated in Weitzman ECHO clinics routinely report high satisfaction and greater confidence in their ability to treat patients.
To learn how your health center can participate or how the Weitzman Institute can create programs for your organization, contact Agi Erickson at 860-622-1667.
The Weitzman Institute is the research and innovation arm of Community Health Center, Inc., dedicated to inspiring primary care innovation and improving health outcomes for the medically underserved. With its expertise in quality improvement, the Weitzman Institute is partnering with organizations around the globe to transform the primary care delivery system through research, training and education.
